Oct 08, 2026 DISPATCH // HARDWARE, CODE & PLATFORMS

Core Tracks

View All Topics →

Shaperon pivots NuGel to steroid combo after solo trial falls short in atopic dermatitis

Shaperon is dropping its solo NuGel plan and turning to a steroid combination, aiming for safer, longer-term atopic dermatitis care after clinical setbacks.

By Evan Solberg

Tech Guides & How-To

All Guides →

Latest Dispatches